Eric G. Carter - 21 May 2025 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
Director
Signature
/s/ Alexander Wilson, as attorney-in-fact for Eric G. Carter
Issuer symbol
AEON
Transactions as of
21 May 2025
Transactions value $
$0
Form type
4
Filing time
23 May 2025, 16:50:53 UTC
Previous filing
04 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carter Eric G Director 5 PARK PLAZA, SUITE 1750, IRVINE /s/ Alexander Wilson, as attorney-in-fact for Eric G. Carter 23 May 2025 0001387660

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Restricted Stock Units Award $0 +308,641 $0.000000 308,641 21 May 2025 Class A Common Stock 308,641 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") will be settled in cash based on the fair market value of the Issuer's Class A Common Stock on the applicable vesting date.
F2 100% of the RSUs shall vest in full on the one year anniversary of May 21, 2025.